Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1995
08/08/1995US5439882 Blood substitute
08/08/1995US5439824 Increased expression of α-1-antitrypsin in expression vectors through the inclusion of intron II
08/08/1995US5439820 Anti-thrombin polypeptides
08/08/1995US5439818 Wound healing agents
08/08/1995US5439815 Restrictocin-like ribotoxin analogues comprising only one cysteine available for covalent linkage to a partner
08/08/1995US5439795 Cystine residue linked to glycine residue at the end of carboxy terminus of peptide; animal growth regulator
08/08/1995US5439688 Process for preparing a pharmaceutical composition
08/08/1995US5439680 Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody as an effective component
08/08/1995US5439679 Peptide plasminogen activators
08/08/1995US5439591 Feeding crude hemoglobin solution to column under anionic exchange conditions to bind more acidic components until column is overloaded and hemoglobin is displaced, feeding eluent to cationic column to bind more basic components
08/08/1995CA1336585C Method of stabilizing urokinase precursor and dry preparation containing said precursor
08/08/1995CA1336579C Delivery systems for the controlled administration of lhrh analogs
08/08/1995CA1336578C Antiviral composition containing a hybrid _-interferon and its use
08/05/1995CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications
08/03/1995WO1995020678A1 Human dna mismatch repair proteins
08/03/1995WO1995020673A1 Organo-phosphorus compounds as activators of gamma delta t cells
08/03/1995WO1995020672A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
08/03/1995WO1995020671A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
08/03/1995WO1995020667A1 cDNA AND GENOMIC CLONES ENCODING HUMAN ν OPIATE RECEPTOR AND THE PURIFIED GENE PRODUCT
08/03/1995WO1995020666A2 Transgenic non-human mammals with progressive neurologic disease
08/03/1995WO1995020661A1 Materials and methods for management of hyperacute rejection in human xenotransplantation
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020659A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
08/03/1995WO1995020658A2 Diagnosis and treatment of infections due to streptococci and enterococci
08/03/1995WO1995020656A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995WO1995020655A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/03/1995WO1995020650A1 Strain of trichoderma harzianum rifai, process for obtaining l-lysine-alpha-oxidase as an inhibitor of viral and bacterial activity, immunomodulator and skin healing agent
08/03/1995WO1995020605A1 Immuno-stimulatory monoclonal antibodies
08/03/1995WO1995020604A1 Antibodies to mammalian natural killer antigens and uses
08/03/1995WO1995020603A1 Inhibitors of serine proteases, bearing a chelating group
08/03/1995WO1995020602A2 ANALOGS OF THYMOSIN α¿1?
08/03/1995WO1995020599A1 B cell epitope of mite allergen
08/03/1995WO1995020581A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995WO1995020404A1 Triplex-forming paired-ion oligonucleotides and methods for preparing and using same
08/03/1995WO1995020402A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995WO1995020401A1 Polyclonal antibody libraries
08/03/1995WO1995020400A1 Anti-inflammatory containing monoclonal antibodies having reactivity with sialyl-lewis x sugar chains originating in hemangioendothelial cell membrane
08/03/1995WO1995020399A1 Pharmaceutical compositions comprising hirudin
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995020397A1 Phosphacan, nucleic acids encoding thereof and antibodies thereto
08/03/1995WO1995020396A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995WO1995020395A1 Atopic disease remedy
08/03/1995WO1995020379A1 Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes
08/03/1995WO1995020320A1 Self-assembling multimeric nucleic acid constructs
08/03/1995WO1995016430A3 Cosmetic and/or pharmaceutical preparations
08/03/1995WO1995014038A3 Purification of hemoglobin
08/03/1995WO1995012660A3 Recombinant p53 adenovirus methods and compositions
08/03/1995CA2182489A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
08/03/1995CA2182380A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
08/03/1995CA2182311A1 Transgenic non-human mammals with progressive neurologic disease
08/03/1995CA2182215A1 Anti-inflammatory containing monoclonal antibodies having reactivity with sialyl-lewis x sugar chains originating in hemangioendothelial cell membrane
08/03/1995CA2182206A1 Human dna mismatch repair proteins
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2182203A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/03/1995CA2181907A1 Pharmaceutical compositions comprising hirudin
08/03/1995CA2181602A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
08/03/1995CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995CA2180528A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995CA2180443A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/03/1995CA2179889A1 Inhibitors of serine proteases, bearing a chelating group
08/03/1995CA2141642A1 Thrombocyte-stabilizing factor ix-fragments, their preparation and use and drugs containing these
08/02/1995EP0665289A2 Peptides from GAD65, provoking autoimmune reactions
08/02/1995EP0665215A1 1,4-Diamino-2,3-dihydroxybutanes
08/02/1995EP0665019A1 Stable dry powders containing hirudin
08/02/1995EP0665013A1 Method of treating hyperproliferative vascular disease
08/02/1995EP0665012A1 Antiallergy agent and nutritional composition containing glutamine and process for the production thereof
08/02/1995EP0664834A1 Recombinant humanized anti-cytomegalovirus antibodies
08/02/1995EP0664832A1 Remyelination using neural stem cells
08/02/1995EP0664814A1 Lipopolysaccharide-binding and neutralizing peptides
08/02/1995EP0664813A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
08/02/1995EP0664711A1 Peptide inhibitors of cellular adhesion
08/02/1995EP0664710A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF
08/02/1995EP0631586A4 Amino procollagen 1(i) peptides.
08/02/1995EP0525163B1 Binding of growth hormone to liposomes
08/02/1995EP0489860B1 Methods and compositions for healing ulcers
08/02/1995EP0429586B1 Growth hormone fusion proteins
08/02/1995CN1106003A Inhibitors of microsomal triglyceride transfer protein and method
08/02/1995CN1105882A Parathyroid hormone and raloxifene for increasing bone mass
08/01/1995US5438121 Brain derived neurotrophic factor
08/01/1995US5438119 Preferential binding of peptide having desired activity or receptivity, then separation from mixed peptides
08/01/1995US5438118 Peptide mimics having constrained peptide backbone
08/01/1995US5438117 Bactericides
08/01/1995US5438075 Oral glutamine to reduce stomatitis
08/01/1995US5438041 Oxygen carrying multiple emulsions
08/01/1995US5438040 Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
08/01/1995US5437958 Human β2 integrin α subunit
08/01/1995US5437865 Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium
08/01/1995US5437864 Removing blood from patient, administering a monoclonal antibody to neutralization
08/01/1995US5437863 Administering interleukin-11,-6, leukemia inhibitory factor, oncostatin M or ciliary neurotrophic factor; regeneration of intestines, stomach, skin, hair sperm and liver cells; chemo- or radiation therapy
08/01/1995US5437291 Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
08/01/1995CA2141523A1 Compound, process for its preparation and its use in stimulating sperm motility
08/01/1995CA2065008C Light activated acyl-enzymes
08/01/1995CA1336528C Antimalarial amnioquinoline derivatives, process for their preparation and pharmaceutical composition containing them
08/01/1995CA1336497C Immunoconjugates for cancer diagnosis and therapy
08/01/1995CA1336493C Pharmaceutically active combination of plasminogen activator and thrombin inhibitor
08/01/1995CA1336492C Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon
08/01/1995CA1336491C Antiviral pharmaceutical composition
08/01/1995CA1336489C Molecular decoyants and methods of use thereof
07/1995
07/27/1995WO1995020048A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
07/27/1995WO1995020045A1 Antibodies to egf receptor and their antitumour effect
1 ... 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 ... 3163